Amazon cover image
Image from Amazon.com
Image from Google Jackets

CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Chapter 11 : Strategies for Development of New Lead Structures for Inhibition of Acetylcholinesterase / editors, E. A. Rekka and P. N. Kourounakis

Contributor(s): Material type: ArticleArticlePublication details: Boca Raton, Florida : CRC Press, ©2008Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 0849390060
  • 9780849390067
Subject(s): DDC classification:
  • RS403.C424 2007 615.19
Online resources:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Chapter in Books Halal Development Corporation Library Open Shelves EBCH 000879 (Browse shelf(Opens below)) Available
Browsing Halal Development Corporation Library shelves, Shelving location: Open Shelves Close shelf browser (Hides shelf browser)
EBCH 000876 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. From the Molecular Pharmacology to the Medicinal Chemistry of Cannabinoids / Chapter 8 : EBCH 000877 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. An Appraisal of Fomocaines: Current Situation and Outlook / Chapter 9 : EBCH 000878 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Ligands for the GABA Recognition Site at the GABAA Receptor: Structure-Activity Studies / Chapter 10 : EBCH 000879 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Strategies for Development of New Lead Structures for Inhibition of Acetylcholinesterase / Chapter 11 : EBCH 000880 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Discovery of Potent and Selective Inhibitors of Human Aldosterone Synthase (CYP11B2): A New Target for the Treatment of Congestive Heart Failure and Myocardial Fibrosis-A Review / Chapter 12 : EBCH 000881 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Thiocarboxanilides: A New Class of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) with Great Potential for the Treatment of Human Immunodeficiency Virus Type 1 (HIV-l) Infections / Chapter 13 : EBCH 000882 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Histamine H3-Receptor Agonists and Antagonists: Chemical, Pharmacological, and Clinical Aspects / Chapter 14 :

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close
Halal Development Corporation Berhad (HDC)
5.02 Level 5, KPMG Tower, First Avenue, Persiaran Bandar Utama, 47800 Petaling Jaya, Selangor Darul Ehsan
Phone: +603 7965 5489 Email: [email protected]